🇺🇸 FDA
Pipeline program

Zydena (Udenafil)

SMC 2011-05-042

Phase 2 small_molecule active

Quick answer

Zydena (Udenafil) for Vascular Dementia is a Phase 2 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Samsung Bioepis NL B.V.
Indication
Vascular Dementia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials